Breaking News Instant updates and real-time market news.

AMGN

Amgen

$203.95

4.74 (2.38%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19

Amgen downgraded to Neutral from Buy at Mizuho

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

AMGN Amgen
$203.95

4.74 (2.38%)

08/12/19
SBSH
08/12/19
NO CHANGE
SBSH
Amgen a 'cleaner' story with Enbrel overhang removed, says Citi
Citi analyst Mohit Bansal says the favorable Enbrel patent ruling makes Amgen a "cleaner biotech story." This was a key overhang on Amgen, and the removal could let investors become more constructive on the company's pipeline, Bansal tells investors in a research note. Further, the analyst thinks Amgen's legacy business decline is now approaching an inflection point where other products could offset it. He keeps a Buy rating on Amgen shares.
08/12/19
LEHM
08/12/19
NO CHANGE
Target $31
LEHM
Overweight
Coherus should be bought on weakness from Enbrel ruling, says Barclays
Barclays analyst Balaji Prasad recommends buying shares of Coherus Biosciences (CHRS) on any weakness from Amgen's (AMGN) favorable Enbrel patent ruling against Novartis (NVS). Coherus is developing its own Enbrel generic, says the analyst, whose model already factors a launch in Q2 of 2029, following the expiration of the last U.S. Enbrel patent. As such, Prasad is making no change to his estimates following Friday's decision. He remains positive on Coherus and would use any share weakness as an opportunity to add a "fundamentally sound company." Prasad reiterates an Overweight rating on the shares with a $31 price target.
08/12/19
WELS
08/12/19
NO CHANGE
Target $202
WELS
Market Perform
Amgen price target raised to $202 from $197 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Amgen to $202 from $197 following the positive District Court decision on ENBREL patents. With validity of ENBREL patents affirmed, the analyst also adjusted his sales estimates to reflect stable trends, and lack of biosimilar erosion beyond 2019. Nonetheless, Birchenough reiterates a Market Perform rating on the shares as he believes the stock is fully-valued relative to growth, even with upward revision to ENBREL estimates.
08/13/19
OPCO
08/13/19
NO CHANGE
Target $230
OPCO
Outperform
Amgen price target raised to $230 from $210 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Amgen (AMGN) to $230 from $210 after the U.S. District Court determined that Sandoz has not met the burden to prove all seven asserted claims invalid and upheld several Enbrel patents. The analyst suspects Sandoz will appeal but views the outcome as highly favorable for Amgen and models flat Enbrel sales until 2021 before declining. Sandoz is a division of Novartis (NVS). Olson reiterates an Outperform rating on Amgen's shares.

TODAY'S FREE FLY STORIES

FE

FirstEnergy

$48.10

0.01 (0.02%)

06:17
09/20/19
09/20
06:17
09/20/19
06:17
Downgrade
FirstEnergy rating change  »

FirstEnergy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

NFLX

Netflix

$286.58

-4.97 (-1.70%)

06:17
09/20/19
09/20
06:17
09/20/19
06:17
Periodicals
Netflix CEO plans to make 'big increase' in buying U.K. content, Reuters reports »

Netflix plans to make a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

GL

Globe Life

$94.34

-0.59 (-0.62%)

06:15
09/20/19
09/20
06:15
09/20/19
06:15
Initiation
Globe Life initiated  »

Globe Life initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$220.91

-1.8 (-0.81%)

06:14
09/20/19
09/20
06:14
09/20/19
06:14
Recommendations
Apple analyst commentary  »

Apple's new iPhone…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$8.19

0.04 (0.49%)

06:12
09/20/19
09/20
06:12
09/20/19
06:12
Upgrade
Ericsson rating change  »

Ericsson upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

STX

Seagate

$52.85

-3.89 (-6.86%)

06:12
09/20/19
09/20
06:12
09/20/19
06:12
Recommendations
Seagate analyst commentary  »

Seagate price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$51.58

-0.15 (-0.29%)

06:12
09/20/19
09/20
06:12
09/20/19
06:12
Periodicals
Intel increasing EUV equipment, material purchases, DigiTimes reports »

Intel has started placing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

AMZN

Amazon.com

$1,822.21

4.21 (0.23%)

06:10
09/20/19
09/20
06:10
09/20/19
06:10
Periodicals
Amazon CEO announces goal to be carbon neutral by 2040, CNBC reports »

Amazon CEO Jeff Bezos has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

RAMP

LiveRamp

$46.44

0.43 (0.93%)

06:10
09/20/19
09/20
06:10
09/20/19
06:10
Upgrade
LiveRamp rating change  »

LiveRamp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCP

TC PipeLines

06:07
09/20/19
09/20
06:07
09/20/19
06:07
Upgrade
TC PipeLines rating change  »

TC PipeLines upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPAM

Epam Systems

$185.46

0.86 (0.47%)

06:07
09/20/19
09/20
06:07
09/20/19
06:07
Initiation
Epam Systems initiated  »

Epam Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$190.15

1.96 (1.04%)

06:06
09/20/19
09/20
06:06
09/20/19
06:06
Periodicals
Person dies by suicide at Facebook headquarters in Menlo Park, BI reports »

A Facebook employee has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

CTSH

Cognizant

$63.44

-0.07 (-0.11%)

06:06
09/20/19
09/20
06:06
09/20/19
06:06
Initiation
Cognizant initiated  »

Cognizant initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$190.15

1.96 (1.04%)

06:05
09/20/19
09/20
06:05
09/20/19
06:05
Hot Stocks
Trump says 'nice meeting with' Facebook CEO Mark Zuckerberg »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

XLNX

Xilinx

$103.59

-1.3 (-1.24%)

06:04
09/20/19
09/20
06:04
09/20/19
06:04
Downgrade
Xilinx rating change  »

Xilinx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SAIC

SAIC

$83.88

-0.46 (-0.55%)

06:03
09/20/19
09/20
06:03
09/20/19
06:03
Initiation
SAIC initiated  »

SAIC initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$87.37

-0.21 (-0.24%)

06:02
09/20/19
09/20
06:02
09/20/19
06:02
Initiation
Leidos initiated  »

Leidos initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$224.49

-1.76 (-0.78%)

06:01
09/20/19
09/20
06:01
09/20/19
06:01
Initiation
CACI initiated  »

CACI initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAH

Booz Allen

$72.55

0.62 (0.86%)

06:00
09/20/19
09/20
06:00
09/20/19
06:00
Initiation
Booz Allen initiated  »

Booz Allen initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 01

    Nov

GIB

CGI Group

$78.68

0.83 (1.07%)

05:58
09/20/19
09/20
05:58
09/20/19
05:58
Initiation
CGI Group initiated  »

CGI Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$194.77

0.66 (0.34%)

05:57
09/20/19
09/20
05:57
09/20/19
05:57
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

COST

Costco

$287.80

-4.67 (-1.60%)

05:55
09/20/19
09/20
05:55
09/20/19
05:55
Upgrade
Costco rating change  »

Costco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

NXST

Nexstar

$102.01

-1.18 (-1.14%)

, TRCO

Tribune Media

$46.66

(0.00%)

05:43
09/20/19
09/20
05:43
09/20/19
05:43
Conference/Events
Nexstar to host conference call »

Conference call to…

NXST

Nexstar

$102.01

-1.18 (-1.14%)

TRCO

Tribune Media

$46.66

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 13

    Nov

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

05:35
09/20/19
09/20
05:35
09/20/19
05:35
Conference/Events
SMTC Corp. to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 12

    Nov

ENLAY

Enel

$0.00

(0.00%)

05:32
09/20/19
09/20
05:32
09/20/19
05:32
Upgrade
Enel rating change  »

Enel upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.